Knowledge-Informed Machine Learning for Cancer Diagnosis and Prognosis: A Review
Lingchao Mao1, Hairong Wang1, Leland S Hu2
1H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA 30332 USA.
Summary
Knowledge-informed machine learning (KIML) enhances cancer diagnosis and prognosis by integrating biomedical knowledge with data-driven models. This approach addresses challenges like limited data and improves model accuracy and interpretability.
Area of Science:
- Oncology
- Artificial Intelligence
- Bioinformatics
Background:
- Machine learning (ML) aids cancer diagnosis and prognosis through complex data analysis.
- ML models face limitations including small sample sizes, high-dimensional data, patient heterogeneity, and interpretability issues.
- Integrating biomedical knowledge into ML models can enhance accuracy, robustness, and interpretability.
Purpose of the Study:
- To review state-of-the-art machine learning studies that fuse biomedical knowledge and data for cancer research.
- To explore knowledge-informed machine learning (KIML) applications in cancer diagnosis and prognosis.
- To discuss future directions for KIML in advancing cancer research and healthcare automation.
Main Methods:
- Review of current literature on knowledge-informed machine learning in oncology.
- Analysis of diverse knowledge representation forms and integration strategies.
- Examination of concrete examples of KIML in cancer diagnosis and prognosis.
Main Results:
- KIML demonstrates potential to overcome ML limitations in cancer research.
- Successful integration of biomedical knowledge improves ML model performance.
- Diverse strategies exist for representing and integrating knowledge into ML pipelines.
Conclusions:
- KIML is a promising approach to advance cancer diagnosis and prognosis.
- Further research into KIML can enhance healthcare automation in oncology.
- An evolving online resource is available to support KIML research in cancer.
Related Concept Videos
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K


